Replies to post #587304 on NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

pqr, also the third one, the Product Release launch pad work that flipper pointed out what LP was explaining at the ASM, is a completely new knowhow in this personalized cell therapy world. LP is thinking ahead of any other biopharma in this field as she is putting together all these new things as quick as possible in taking DcVaxL to the patients.

[ATLnsider]

pqr, unfortunately, the loudest voices in most cases, are the negative voices. These voices purposely try to drown out facts, truth, science and data.

An investment in NWBO is not easy, and it is complicated. This investment is not for everyone. It requires a lot of patience and conviction. You have to be able to “tune out the negative voices, and make investment decisions based on facts and truth.

Most retail investors will not take the time needed to do the necessary research and due diligence. A lot of potential investors are frightened off by the negative voices.

Fortunately, especially for solid tumor cancer patients around the world, DCVax-L and DCVax Direct will be approved. They are both tumor and tissue agnostic, and will benefit millions of cancer patients in the future.